Posters ECNP Workshop 2012

P.1 Molecular neuropsychopharmacology
P.2 Behavioural pharmacology
P.3 Clinical neuropsychopharmacology
P.4 Depression: towards new drug targets

P.1 Molecular neuropsychopharmacology
P.1.002  (PDF 269 kb)
Role of 5-HT2A-receptor and a2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow
Olivia Frånberg, Sweden
P.1.003  (PDF 346 kb)
Brain-derived neurotrophic factor as a biomarker of clinical response in bipolar disorder: 16-week follow-up study
Iria Grande, Spain
P.1.004  (PDF 243 kb)
Lower BDNF levels in schizophrenia than in control population: a case-control study
Alicia Valiente, Spain
P.1.006  (PDF 340 kb)
Stimulation of D3 receptors activates Akt/GSK-3beta and mTOR signalling pathways in nucleus accumbens and striatum
Marie-Josèphe Salles, France
P.1.007  (PDF 150 kb)
Time-course analysis of hormonal and neuroplastic changes in rats exposed to prenatal stress
Alessia Luoni, Italy
P.1.009  (PDF 4,33 mb)
Increased mRNA expression and release of neuropeptide S after REM sleep deprivation in rat.
Csaba Adori, Sweden
P.1.011  (PDF 530 kb)
Identifying transcriptomic biomarkers for response to escitalopram in the inflammatory cytokine pathway
Timothy Powell, United Kingdom
P.1.012  (PDF 728 kb)
Protein kinase C inhibition rescues manic-like behaviour and impairment of hippocampal cell proliferation induced by sleep deprivation
Erika Abrial, France
P.1.013  (PDF 873 kb)
Variants in catechol-o-methyltransferase gene are associated with impulsivity and executive function: relevance for major depression
Dorottya Pap, Hungary
P.1.014  (PDF 187 kb)
Spatial memory and expression levels of BDNF and steroid hormone receptors in the hippocampus of social isolated offspring
Pierluigi Olla, Italy
P.1.015  (PDF 405 kb)
Selective methylation of brain derived neurotrophic factor gene promoter in bipolar disorder: differences between patients and controls
Beatrice Benatti, Italy
P.1.016  (PDF 338 kb)
The role of nitric oxide signalling in impulsive behaviours
Aet Alttoa, Germany
P.1.017  (PDF 182 kb)
Stress-induced enhancement of synaptic plasticity in the amygdala of mice depends on both glucocorticoid and ß-adrenergic activity
Ratna Angela Sarabdjitsingh, The Netherlands
P.1.019  (PDF 811 kb)
Does the progranulin gene variability decrease the risk to develop bipolar disorder and schizophrenia?
M.Carlotta Palazzo, Italy
P.1.021  (PDF 792 kb)
Longitudinal changes of n-acetyl-aspartate in early onset psychosis
Marta Rapado-Castro, Spain
P.1.025  (PDF 638 kb)
Restoration of oscillatory changes in the genetic NMDA receptor hypofunction mutant PV-Cre/NR1f/f,
Xinming Wang, Sweden
P.1.026  (PDF 1,49 mb)
Sub-chronic phencyclidine alters GABAergic gene expression in rat frontal cortex: focus on tonic inhibition and its relevance to cognition
James Glasper, United Kingdom
P.1.030  (PDF 652 kb)
Antagonist dissociation from dopamine D2 receptors: studies using a time-resolved ion channel activation assay
Kristoffer Sahlholm, Sweden
P.2 Behavioural pharmacology
P.2.001  (PDF 385 kb)
Differential effects of central oxytocin on social versus cued fear
Iulia Toth, Germany
P.2.002  (PDF 74 kb)
Positive allosteric modulation of metabotropic glutamate 5 receptors prevents and reverses social discrimination deficits in rats
Nadège Morisot, France
P.2.003  (PDF 1,07 mb)
Inhibition of the phosphatidylinositol-3 kinase cascade in corticolimbic structures: possible target to erase fear memories
Milly Kritman, Israel
P.2.006  (PDF 1,02 mb)
Ontogeny of cognitive impairment following prenatal infection
Juliet Richetto, Italy
P.2.008  (PDF 1 mb)
Neurobiological correlates of cocaine-induced anxiety in withdrawn rats
Cynthia El Hage, France
P.2.009  (PDF 650 kb)
The effect of acutely induced anxiety in a successive negative contrast task in humans
Michael Anderson, United Kingdom
P.2.010  (PDF 450 kb)
Carbon dioxide-induced anxiety and the successive negative contrast effect in rats 
Emma Mitchell, United Kingdom
P.2.011  (PDF 2,19 mb)
Decreased levels of allopregnanolone induced by oral contraceptives is associated with a reduction in social behaviour and sexual motivation in rats
Roberta Berretti, Italy
P.2.012  (PDF 925 kb)
Long-lasting memory abnormalities following exposure to the mouse defense test battery
Julie Philbert, France
P.2.013  (PDF 823 kb)
Effects of melatonin on diurnal variations of spontaneous seizures and behavioural changes in kainate model of temporal lobe epilepsy
Zlatina Petkova, Bulgaria
P.2.014  (PDF 1,46 mb)
Potentiation of donepezil efficiency profile by connexins inhibitors in aged related cognitive impairment
Matthias Vandesquille, France
P.2.015  (PDF 295 kb)
An anxiolytic but not antidepressant-like activity of a novel positive modulator of mGlu4 receptor Lu AF21394
Anna Slawinska, Poland
P.2.016  (PDF 1,02 mb)
Changes in basal and fluoxetine-induced adult neurogenesis and depression-related behaviours in transgenic S100B over-expressing mice
Vasco Sousa, Sweden
P.2.018  (PDF 790 kb)
Antidepressants specifically inhibiting noradrenaline reuptake enhance recognition memory in rats
Kristin Feltmann, Sweden
P.2.019  (PDF 141 kb)
BDNF/TrkB signaling in learning and memory: the effects of 7,8-dihydroxyflavone on object memory
Eva Bollen, The Netherlands
P.2.020  (PDF 1,20 mb)
Housing conditions affect memory performance and drug efficacy in the rat
Sven Akkerman, The Netherlands
P.3 Clinical neuropsychopharmacology
P.3.003  (PDF 785 kb)
The need for antidepressants in chronic haemodialysis
Costin Roventa, Romania
P.3.004  (PDF 1,79 mb)
Amphetamine-opioid interactions in the human brain reward system - a PET study using [11C]carfentanil
Joar Guterstam, Sweden
P.3.005  (PDF 1,05 mb)
Tardive dyskinesia and polymorphism of phosphatidylinositol- 4-phosphate 5-kinase IIa gene in Russian schizophrenic patients
Valentina Gavrilova, Russia
P.3.006  (PDF 2,15 mb)
Effect of psychiatric co-morbidity and the method of insulin therapy on metabolic control in children with type 1 diabetes
Agnieszka Butwicka, Poland
P.3.008  (PDF 709 kb)
SLC2A3: a new candidate gene for attention-deficit/hyperactivity disorder
Sören Merker, Germany
P.3.010  (PDF 670 kb)
Genetic variability at IMPA-2, INNP-1 and glycogen synthase kinase (GSK)-3ß increases the risk of suicidal behaviour in bipolar patients
Esther Jimenez, Spain
P.3.011  (PDF 1,56 mb)
Risk factors for suicidal ideation among HIV-infected drinkers in Russia
Tatiana Yaroslavtseva, Russia
P.3.012  (PDF 1,34 mb)
Effectiveness of naltrexone in the double blind placebo controlled clinical trial of naltrexone and guanfacine for heroin dependence
Vladimir Palatkin, Russia
P.3.013  (PDF 4,08 mb)
Neurocognitive impairment in euthymic bipolar disorder: a functional magnetic resonance imaging study with a working memory task
Laura Cremaschi, Italy
P.3.015  (PDF 1 mb)
Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677c->t polymorphism and psychiatric disorders in children
Laura Kevere, Latvia
P.3.016  (PDF 98 kb)
Oxcarbazepine, topiramate and lamotrigine in treatment of alcohol craving
Bojana Bajovic, Serbia
P.3.019   (PDF 756 kb)
Impact of lithium on oxidative stress parameters in human plasma in vitro and neuroblastoma SH-SY5Y oxidative stress level and viability
Oliwia Gawlik, Poland
P.3.020  (PDF 480 kb)
The role of P-glycoprotein in central antihistamine effects
Silke Conen, The Netherlands
P.3.021  (PDF 5,14 mb)
Potential benefits of slow titration of paroxetine treatment in elderly population: 6-month results from a naturalistic setting
Sara Gibiino, Italy
P.3.023  (PDF 1,10 mb)
Metabolic risk after six months of treatment with second-generation antipsychotics in antipsychotic-naïve children and adolescents
Covadonga M. Díaz-Caneja, Spain
P.3.024  (PDF 614 kb)
Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist
Maartje Luijten, The Netherlands
P.3.026  (PDF 728 kb)
Clinical and genetic predictors of antidepressant response and remission in treatment resistant depression
Raffaella Calati, Italy
P.3.027  (PDF 256 kb)
A single dose of the antidepressant fluoxetine modulates emotional processing in young adult volunteers
Liliana Capitao, United Kingdom
P.3.028  (PDF 389 kb)
Antenatal depression and infant sleep 6 months postpartum: examining the moderating effects of the 5-HTTLPR and temperament
Elena Netsi, United Kingdom
P.3.029  (PDF 222 kb)
Chronic cannabis use and dopamine synthesis capacity: an [18F]-DOPA positron emission tomography study
Michael Bloomfield, United Kingdom
P.3.032  (PDF 515 kb)
Acute mediofrontal and insular brain hypoperfusion after heroin administration in addicts: a within subject arterial spin labeling study
Niklaus Denier, Switzerland
P.4 Depression: towards new drug targets
P.4.003  (PDF 223 kb)
A neural cell adhesion molecule (NCAM)-derived peptide, FGL, counteracts serotonergic dysfunction in NCAM-deficient mice
Anu Aonurm-Helm, Estonia
P.4.005  (PDF 118 kb)
Effect of antidepressant drugs on dopamine D2 and somatostatin Sst5 receptors heterodimerisation - fluorescence in vitro studies
Kinga Szafran, Poland
P.4.008  (PDF 4,64 mb)
Larger grey matter volume reductions are related to longer duration of major depressive disorder
Maria Serra, Spain
P.4.014  (PDF 1,06 mb)
Deep brain stimulation in treatment-resistant depression in mice 
Carine Dournes, France
P.4.015  (PDF 80 kb)
Gene expression profile associated with major depression and with antidepressant response
Annamaria Cattaneo, Italy 
P.4.016  (PDF 369 kb)
GABAB(1) receptor subunit isoforms differentially mediate susceptibility to depression-related behaviour following early-life stress
Daniela Felice, Ireland
P.4.017  (PDF 1,34 mb)
Cortisol decreases hippocampal neurogenesis by regulating the enzyme serum- and glucocorticoid-regulated kinase 1 
Christoph Anacker, United Kingdom
P.4.018  (PDF 184 kb)
The effect of acute imipramine on amphetamine-induced striatal dopamine and serotonin release in low and high exploring rats 
Kadri Koiv, Estonia
P.4.019  (PDF 945 kb)
Targeting cognitive impairment in anxiety disorders: transcriptional actions of glucocorticoid receptor modulators
Chinedu Udeh, United Kingdom
P.4.020  (PDF 861 kb)
Fluoxetine acts not only as an antidepressant: inhibitory effect on murine melanoma growth
Beata Grygier, Poland
P.4.022  (PDF 1,38 mb)
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants
Mariagrazia Pelizzari, Italy